Home

Ra Capital Management reported a 12.6% stake in Werewolf Therapeutics HOWL · 6,116,140 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
12.6%
Last report
13.8% · filed 25/11/06
Shares held
6,116,140 sh
Class
Common Stock, $0.0001 par value per share
Event date
26/05/12
Filed
26/05/14

12.6% stake · −1.2pp from the last report

Stake
12.6%
Last report
13.8%
Since last report
−1.2pp

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 04/12~06/11

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03

Ra Capital Management reported a 12.6% stake in Werewolf Therapeutics HOWL · 6,116,140 sh · amendment | Whalegun